Breast cancer patients could benefit from controversial hormone
An international team of researchers involving the University of Adelaide is tackling the controversy over…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
An international team of researchers involving the University of Adelaide is tackling the controversy over…
A drug typically used to treat depression and anxiety can significantly reduce joint pain in…
Genomic sequencing of oestrogen receptor (ER)-positive metastatic breast cancer that had become resistant to therapies…
Five additional years of hormone therapy with letrozole following an initial five years of aromatase…
The discovery of metastasis-promoting protein receptors (CD36) in mouse cells has led to the launch…
Progression-free survival was more than doubled for patients with metastatic hormone receptor (HR)-positive, HER2-negative breast…
A promising new combination therapy for a particularly aggressive form of breast cancer has been…
QIMR Berghofer scientists have found that reversing the order of treatment for patients with certain…
Scientists have created a map of all 1,578 licensed drugs and their mechanisms of action…
New vaccine to protect against 90 per cent of all cervical cancers, instead of the…